Literature DB >> 11114166

Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation.

J E Kim1, J Chen.   

Abstract

Translation initiation is one of the key events regulated in response to mitogenic stimulation and nutrient availability, tightly coupled to mammalian cell cycle progression and growth. FKBP12-rapamycin-associated protein (FRAP; also named mTOR or RAFT1), a member of the ataxia telangiectasia mutated (ATM)-related kinase family, governs a rapamycin-sensitive membrane-to-cytoplasm signaling cascade that modulates translation initiation via p70 S6 kinase (p70(s6k)) and eIF-4E binding protein 1 (4E-BP1). Our studies reported here reveal a surprising regulatory mechanism of this signaling, which involves cytoplasmic-nuclear shuttling of FRAP. By using leptomycin B (LMB), a specific inhibitor of nuclear export receptor Crm1, we show that FRAP is a cytoplasmic-nuclear shuttling protein. Inhibition of FRAP nuclear export by LMB coincides with diminished p70(s6k) activation and 4E-BP1 phosphorylation. Further investigation by altering FRAP's nuclear shuttling activity with exogenous nuclear import and export signals has yielded results that are consistent with a direct link between nuclear shuttling of FRAP and mitogenic stimulation of p70(s6k) activation and 4E-BP1 phosphorylation. Furthermore, by using a reporter system, we provide evidence suggesting that nuclear shuttling of FRAP regulates mitogen-stimulated rapamycin-sensitive translation initiation. These findings uncover a function for the nucleus in the direct regulation of the protein synthesis machinery via extracellular signals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114166      PMCID: PMC18920          DOI: 10.1073/pnas.011511898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.

Authors:  D M Sabatini; H Erdjument-Bromage; M Lui; P Tempst; S H Snyder
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

Review 2.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors.

Authors:  C Hu; S Pang; X Kong; M Velleca; J C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

4.  Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); a novel nuclear target of Akt.

Authors:  H Koh; K Jee; B Lee; J Kim; D Kim; Y H Yun; J W Kim; H S Choi; J Chung
Journal:  Oncogene       Date:  1999-09-09       Impact factor: 9.867

5.  Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family.

Authors:  H B Jefferies; C Reinhard; S C Kozma; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins.

Authors:  N Terada; H R Patel; K Takase; K Kohno; A C Nairn; E W Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

7.  Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function.

Authors:  A Pause; G J Belsham; A C Gingras; O Donzé; T A Lin; J C Lawrence; N Sonenberg
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

8.  Complete nucleotide sequence and characterization of the 5'-flanking region of mammalian elongation factor 2 gene.

Authors:  T Nakanishi; K Kohno; M Ishiura; H Ohashi; T Uchida
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

9.  A mammalian protein targeted by G1-arresting rapamycin-receptor complex.

Authors:  E J Brown; M W Albers; T B Shin; K Ichikawa; C T Keith; W S Lane; S L Schreiber
Journal:  Nature       Date:  1994-06-30       Impact factor: 49.962

10.  Nuclear localization of p85s6k: functional requirement for entry into S phase.

Authors:  C Reinhard; A Fernandez; N J Lamb; G Thomas
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more
  63 in total

Review 1.  The target of rapamycin (TOR) proteins.

Authors:  B Raught; A C Gingras; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

2.  Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxis.

Authors:  P Campoli; Q Al Abdallah; R Robitaille; N V Solis; J A Fielhaber; A S Kristof; M Laverdiere; S G Filler; D C Sheppard
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

Review 3.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

4.  Reduction in ribosomal protein synthesis is sufficient to explain major effects on ribosome production after short-term TOR inactivation in Saccharomyces cerevisiae.

Authors:  Alarich Reiter; Robert Steinbauer; Anja Philippi; Jochen Gerber; Herbert Tschochner; Philipp Milkereit; Joachim Griesenbeck
Journal:  Mol Cell Biol       Date:  2010-12-13       Impact factor: 4.272

5.  A Unique Homeostatic Signaling Pathway Links Synaptic Inactivity to Postsynaptic mTORC1.

Authors:  Fredrick E Henry; Xiao Wang; David Serrano; Amanda S Perez; Cynthia J L Carruthers; Edward L Stuenkel; Michael A Sutton
Journal:  J Neurosci       Date:  2018-01-08       Impact factor: 6.167

6.  TOR1 and TOR2 have distinct locations in live cells.

Authors:  Thomas W Sturgill; Adiel Cohen; Melanie Diefenbacher; Mark Trautwein; Dietmar E Martin; Michael N Hall
Journal:  Eukaryot Cell       Date:  2008-08-22

7.  PPAR Gamma Coactivator 1 Beta (PGC-1β) Reduces Mammalian Target of Rapamycin (mTOR) Expression via a SIRT1-Dependent Mechanism in Neurons.

Authors:  Ying-Chun Liu; Xiao-Xiao Gao; Zhi-Guang Zhang; Zhao-Hua Lin; Qi-Lian Zou
Journal:  Cell Mol Neurobiol       Date:  2016-09-15       Impact factor: 5.046

8.  Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Authors:  Francisco Vega; L Jeffrey Medeiros; Vasiliki Leventaki; Coralyn Atwell; Jeong Hee Cho-Vega; Ling Tian; Francois-Xavier Claret; George Z Rassidakis
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

9.  Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response.

Authors:  Sricharan Bandhakavi; Young-Mi Kim; Seung-Hyun Ro; Hongwei Xie; Getiria Onsongo; Chang-Bong Jun; Do-Hyung Kim; Timothy J Griffin
Journal:  Mol Cell Proteomics       Date:  2009-11-23       Impact factor: 5.911

10.  Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization of NFATc4.

Authors:  Teddy T C Yang; Raymond Y L Yu; Anissa Agadir; Guo-Jian Gao; Roberto Campos-Gonzalez; Cathy Tournier; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.